TY  - GEN
AU  - Ferrante,K L
AU  - Shefner,J
AU  - Zhang,H
AU  - Betensky,R
AU  - O'Brien,M
AU  - Yu,H
AU  - Fantasia,M
AU  - Taft,J
AU  - Beal,M F
AU  - Traynor,B
AU  - Newhall,K
AU  - Donofrio,P
AU  - Caress,J
AU  - Ashburn,C
AU  - Freiberg,B
AU  - O'Neill,C
AU  - Paladenech,C
AU  - Walker,T
AU  - Pestronk,A
AU  - Abrams,B
AU  - Florence,J
AU  - Renna,R
AU  - Schierbecker,J
AU  - Malkus,B
AU  - Cudkowicz,M
TI  - Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS
SN  - 1526-632X
PY  - 2006///0323
KW  - Amyotrophic Lateral Sclerosis
KW  - drug therapy
KW  - Central Nervous System
KW  - drug effects
KW  - Coenzymes
KW  - Dose-Response Relationship, Drug
KW  - Drug Tolerance
KW  - physiology
KW  - Energy Metabolism
KW  - Female
KW  - Free Radical Scavengers
KW  - administration & dosage
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Mitochondria
KW  - Nerve Degeneration
KW  - Neurons
KW  - Neuroprotective Agents
KW  - Ubiquinone
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1212/01.wnl.0000187070.35365.d7
ER  -